SuperMeat will test continuous bioprocessing technology in cultivated meat production.
Stämm, an Argentinian biopharma company, and SuperMeat, an Israeli cultivated meat firm, have partnered to accelerate cultivated meat biomanufacturing.
The collaboration is aimed at enhancing production of SuperMeat's cultivated chicken with Stämm's novel bubble-free bioreactor, which has displayed cost savings and increased productivity in the pharma sector.
The companies are specifically focused on enhancing muscle…
Join for free* to continue reading.
You’ll get access to all Alt-Meat has to offer including full access to our web content devoted to the meat alternatives market.
Already a member? Click here to login>>.
*Free for qualified recipients